The purpose of this study is to compare the clinical effectiveness of two types of chiropractic spinal manipulation to conservative medical care for patients at least 55 years old with sub-acute or chronic low back pain (LBP)...
Date First Received: January 15, 2008
Last Updated: September 15, 2008
Verified by: Palmer College of Chiropractic, September 2008
Clinical Trial Phase: Phase 2 | Start Date: July 2004
Overall Status: Completed
Estimated Enrollment: 240
Brief Summary
Official Title: “Elderly Back Pain: Comparing Chiropractic to Medical Care”
Condition Keyword(s):
The purpose of this study is to compare the clinical effectiveness of two types of chiropractic spinal manipulation to conservative medical care for patients at least 55 years old with sub-acute or chronic low back pain (LBP).
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Study Primary Completion Date: October 2006
Detailed Clinical Trial Description
Despite the high prevalence of LBP and the associated economic costs, disability, and lost productivity, and despite the development of several treatment guidelines, one of which recommends chiropractic spinal manipulation for some subgroups of patients with pack pain, the management of LBP remains controversial and highly variable across professions and geographic regions. Although one recent publication describes the design of chiropractic and exercise for seniors with low back or neck pain, no published studies to our knowledge, have assessed the effectiveness of chiropractic manipulation compared to medical care for older adults with sub-acute or chronic low back pain.
Intervention(s) in this Clinical Trial
- Other: Spinal manipulation
- High-velocity low amplitude spinal manipulation (HVLA-SM)
- Other: Spinal manipulation
- Low-velocity variable amplitude spinal manipulation (LVVA-SM)
- Drug: Usual medical care (Celebrex, Aleve, Bextra, Naproxen)
- Celebrex: po, 200mg, qd, six weeks; Aleve: po, 220mg, bid, six weeks; Bextra: po, 10mg, qd, six weeks; Naproxen: po, 500mg, bid, six weeks.
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: 1
- High-velocity low amplitude spinal manipulation (HVLA-SM)
- Experimental: 2
- Low-velocity variable amplitude spinal manipulation (LVVA-SM)
- Active Comparator: 3
- Usual medical care
Outcome Measures for this Clinical Trial
Primary Measures
- Roland Morris Disability Questionnaire(RMDQ).
- Time Frame: 6 weeks
Safety Issue?: No
- Time Frame: 6 weeks
Secondary Measures
- Fear Avoidance Beliefs Questionnaire, physical subscale
- Time Frame: 6 weeks, 3 months, 6 months
Safety Issue?: No
- Time Frame: 6 weeks, 3 months, 6 months
- Visual Analogue Scale for Pain
- Time Frame: 6 weeks
Safety Issue?: No
- Time Frame: 6 weeks
- Postural Sway
- Time Frame: 6 weeks
Safety Issue?: No
- Time Frame: 6 weeks
- SF-36, v1, Physical Function subscale
- Time Frame: 6 weeks
Safety Issue?: No
- Time Frame: 6 weeks
- Posteroanterior Spinal Stiffness
- Time Frame: 6 weeks
Safety Issue?: No
- Time Frame: 6 weeks
- Sit-to-Stand Maneuver
- Time Frame: 6 weeks
Safety Issue?: No
- Time Frame: 6 weeks
- Spinal Manipulation
- Time Frame: 6 weeks
Safety Issue?: No
- Time Frame: 6 weeks
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Age 55 or older
- Idiopathic low back pain (LBP) of at least four weeks duration
- Meet the diagnostic classification of 1, 2, or 3 according to the Quebec Task Force on
- Spinal Disorders
Exclusion Criteria:
- Low back pain (LBP) not meeting Quebec Task Force Diagnostic Classifications 1, 2 or 3, especially LBP associated with: frank radiculopathy, altered lower extremity reflex, dermatomal sensory deficit, progressive unilateral muscle weakness or motor loss, symptoms of cauda equina compression, and CT or MRI evidence of anatomical pathology (e.g. abnormal disc, lateral or central stenosis.
- Co-morbid conditions or general poor health that could significantly complicate the prognosis of LBP, including pregnancy, bleeding disorders, extreme obesity, and clear evidence of narcotic or other drug abuse.
- Major clinical depression defined as scores greater that 29 on the Beck Depression
- Inventory - Second Edition
- Bone or joint pathology that contraindicate spinal manipulative therapy of joint pathology that contraindicate spinal maniuplative therapy of the arthropathies and significant osteoporosis
- Pacemaker, because there are safety issues with equipment used to collect data in the biomechanical testing laboratory
- Current or pending litigation related to current episode of LBP.
- Receiving disability for any health-related condition
- Spinal Manipulative care for any reason within the past month
- Unwilling to postpone use of manual therapies for LBP except those provided in the study for the duration of the study period.
- Unable to read or verbally comprehend English.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 55 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Palmer College of Chiropractic
Overall Clinical Trial Officials and Contacts
William C Meeker, DC, M.P.H. Principal Investigator Palmer College of Chiropractic
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00602901
Study ID Number: R18HP01423
ClinicalTrials.gov Identifier: NCT00602901
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.